Signaturefd LLC Trims Position in Kenvue Inc. $KVUE

Signaturefd LLC lessened its stake in Kenvue Inc. (NYSE:KVUE) by 17.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,876 shares of the company’s stock after selling 1,439 shares during the period. Signaturefd LLC’s holdings in Kenvue were worth $144,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Kenvue by 4.9% in the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock worth $5,494,882,000 after acquiring an additional 10,600,682 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Kenvue by 2.5% in the first quarter. Charles Schwab Investment Management Inc. now owns 25,606,238 shares of the company’s stock worth $613,882,000 after acquiring an additional 633,461 shares during the period. Boston Partners lifted its stake in Kenvue by 7.4% in the first quarter. Boston Partners now owns 25,346,453 shares of the company’s stock worth $606,920,000 after acquiring an additional 1,750,490 shares during the period. JPMorgan Chase & Co. lifted its stake in Kenvue by 11.6% in the first quarter. JPMorgan Chase & Co. now owns 24,912,226 shares of the company’s stock worth $597,395,000 after acquiring an additional 2,597,920 shares during the period. Finally, American Century Companies Inc. lifted its stake in Kenvue by 15.7% in the first quarter. American Century Companies Inc. now owns 21,828,854 shares of the company’s stock worth $523,456,000 after acquiring an additional 2,961,716 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on KVUE shares. Citigroup reaffirmed a “neutral” rating on shares of Kenvue in a research note on Tuesday, September 23rd. JPMorgan Chase & Co. lowered their price objective on shares of Kenvue from $27.00 to $26.00 and set an “overweight” rating for the company in a research note on Friday, July 25th. Canaccord Genuity Group lowered their price objective on shares of Kenvue from $29.00 to $26.00 and set a “buy” rating for the company in a research note on Friday, August 8th. Bank of America decreased their price target on shares of Kenvue from $27.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, July 15th. Finally, Rothschild Redb raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $22.46.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $15.80 on Friday. Kenvue Inc. has a twelve month low of $15.47 and a twelve month high of $25.17. The company’s 50 day moving average is $19.71 and its 200 day moving average is $21.58. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The company has a market cap of $30.31 billion, a PE ratio of 21.34, a price-to-earnings-growth ratio of 2.26 and a beta of 0.72.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The company had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the company earned $0.32 EPS. Kenvue’s quarterly revenue was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.3%. The ex-dividend date of this dividend was Wednesday, August 13th. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s dividend payout ratio is 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.